City

Bethesda (1)

Boston (1)

Condition

Adenosquamous Carcinoma of the Pancreas (2)

Adenocarcinoma of the Pancreas (1)

Pancreatic Cancer (1)

Squamous Cell Carcinoma of Pancreas (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

James Cleary, MD, PhD (1)

National Cancer Institute (NCI) (1)

Collaborator

Arcus Biosciences, Inc. (1)

Lustgarten Foundation (1)

Intervention

apx005m (1)

domvanalimab (1)

folfiri (1)

minnelide (1)

zimberelimab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

adenosquamous carcinoma of the pancreas

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,

Recruiting

Pancreatic Cancer
+3 more

ZIMBERELIMAB
+3 more

Boston, Massachusetts

Dana Farber Cancer Institute

Jan 9, 2023

Adenosquamous Carcinoma of the Pancreas Trial run by the NCI (Minnelide)

Recruiting

Adenosquamous Carcinoma of the Pancreas

Minnelide

Bethesda, Maryland

National Institutes of Health Clinical Center

Jul 7, 2022